Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...

At this time, I would like to welcome everyone to the Tempus fourth-quarter 2024 financial results conference call. Thank you, Jason. Good afternoon and welcome to Tempus fourth-quarter 2024 ...

Shares of Tempus AI (NASDAQ:TEM) dropped 19% Tuesday, the day after the AI-focused healthcare company released a Q4 earnings ...

Tempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD.

A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...

Tempus AI Inc (TEM) reports impressive revenue growth, strategic acquisitions, and extended partnerships, setting the stage for a promising 2025.

Reports Q4 revenue $200.7M, consensus $202.8M. “Our performance in 2024 reflects the strength of our core businesses, as Genomics continued to ...

Tempus posted a fourth-quarter adjusted net loss of $0.18 per share, $0.02 more per share than estimates by analysts surveyed ...

Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest since its successful IPO in June 2024. The stock had been on a strong ...